Global Research Team Utilizes Whole Exome Sequencing To Identify Novel Congenital Disorder Of Glycosylation Linked To RPN1 Gene

Researchers at Sanford Burnham Prebys identify a new rare genetic disorder using whole exome sequencing to map mutations in the RPN1 gene.

By: AXL Media

Published: Apr 16, 2026, 7:41 AM EDT

Source: Information for this report was sourced from Sanford Burnham Prebys

Advanced Genomic Mapping Uncovers Hidden Genetic Pathology

A multinational team led by researchers at the Sanford Burnham Prebys Medical Discovery Institute has successfully identified a new rare genetic disease through the application of whole exome sequencing. According to findings published on April 3, 2026, the investigation focused on a specific mutation within the RPN1 gene that interferes with vital cellular functions. This discovery represents an expansion of the known category of congenital disorders of glycosylation, a group of conditions that result from the body's inability to properly construct and attach sugar chains to proteins.

The Biological Significance Of Glycosylation Mechanisms

The newly identified disorder falls under the umbrella of CDG, which currently encompasses more than 190 distinct conditions. According to the research team, glycosylation is a sophisticated biological process where cells create long sugar chains, known as glycans, to modify secreted proteins into glycoproteins. These glycans are critical for protein stability and folding, ensuring that biological molecules can execute their intended functions. When this process is impaired, the resulting system malfunctions can lead to severe organ failure or neurodevelopmental deficits that are often fatal.

Sibling Genomic Comparison Isolates The Pathogenic Mutation

The diagnostic breakthrough began with the genomic analysis of two siblings who presented with an unidentified neurodevelopmental disorder. Scientists discovered a shared genetic error in these siblings that was absent in three other healthy siblings. According to the study, this specific mutation had never been recorded in global genetic databases, marking it as a unique discovery. By isolating this "typo" in the genetic code, the researchers were able to narrow their focus to the RPN1 gene and its impact on the production of the protein ribophorin I.